Results 1 - 20 of 1,120 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (1,081)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney DiseaseThe New England journal of medicine, 2017-11, Vol.377 (20), p.1930-1942 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710030 ;PMID: 29105594Full text available |
| 2 |
Material Type: Article
|
|
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease InternationalNephrology, dialysis, transplantation, 2022-04, Vol.37 (5), p.825-839 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfab312 ;PMID: 35134221Full text available |
| 3 |
Material Type: Article
|
|
A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol DependenceNeuropsychopharmacology (New York, N.Y.), 2017-04, Vol.42 (5), p.1012-1023 [Peer Reviewed Journal]Copyright Nature Publishing Group Apr 2017 ;Copyright © 2017 American College of Neuropsychopharmacology 2017 American College of Neuropsychopharmacology ;ISSN: 0893-133X ;EISSN: 1740-634X ;DOI: 10.1038/npp.2016.214 ;PMID: 27658483 ;CODEN: NEROEWFull text available |
| 4 |
Material Type: Article
|
|
Novel molecular mechanisms in the inhibition of adrenal aldosterone synthesis: Action of tolvaptan via vasopressin V 2 receptor-independent pathwayBritish journal of pharmacology, 2019-05, Vol.176 (9), p.1315-1327 [Peer Reviewed Journal]2019 The British Pharmacological Society. ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.14630 ;PMID: 30801659Full text available |
| 5 |
Material Type: Article
|
|
Response criteria of tolvaptan for the treatment of hepatic edemaJournal of gastroenterology, 2018-02, Vol.53 (2), p.258-268 [Peer Reviewed Journal]Japanese Society of Gastroenterology 2017 ;COPYRIGHT 2018 Springer ;Journal of Gastroenterology is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0944-1174 ;EISSN: 1435-5922 ;DOI: 10.1007/s00535-017-1366-6 ;PMID: 28664229Full text available |
| 6 |
Material Type: Article
|
|
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 TrialClinical journal of the American Society of Nephrology, 2016-05, Vol.11 (5), p.803-811 [Peer Reviewed Journal]Copyright © 2016 by the American Society of Nephrology. ;Copyright © 2016 by the American Society of Nephrology 2016 ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/cjn.06300615 ;PMID: 26912543Full text available |
| 7 |
Material Type: Article
|
|
Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover TrialClinical journal of the American Society of Nephrology, 2022-04, Vol.17 (4), p.507-517 [Peer Reviewed Journal]Copyright © 2022 by the American Society of Nephrology. ;Copyright © 2022 by the American Society of Nephrology 2022 ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.11260821 ;PMID: 35314480Full text available |
| 8 |
Material Type: Article
|
|
Vaptans or voluntary increased hydration to protect the kidney: how do they compare?Nephrology, dialysis, transplantation, 2023-02, Vol.38 (3), p.562-574 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfab278 ;PMID: 34586414Full text available |
| 9 |
Material Type: Article
|
|
Real-life use of tolvaptan in ADPKD: a retrospective analysis of a large Canadian cohortScientific reports, 2023-12, Vol.13 (1), p.22257-22257, Article 22257 [Peer Reviewed Journal]2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-023-48638-9 ;PMID: 38097698Full text available |
| 10 |
Material Type: Article
|
|
Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysisPloS one, 2017-09, Vol.12 (9), p.e0184380-e0184380 [Peer Reviewed Journal]COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Wu et al 2017 Wu et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0184380 ;PMID: 28898297Full text available |
| 11 |
Material Type: Article
|
|
Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325British journal of pharmacology, 2014-07, Vol.171 (14), p.3511-3525 [Peer Reviewed Journal]2014 The British Pharmacological Society ;2014 The British Pharmacological Society. ;Copyright © 2014 The British Pharmacological Society ;2014 The British Pharmacological Society 2014 ;ISSN: 0007-1188 ;EISSN: 1476-5381 ;DOI: 10.1111/bph.12699 ;PMID: 24654684Full text available |
| 12 |
Material Type: Article
|
|
Hyponatremia in cirrhosis:Pathophysiology and managementWorld journal of gastroenterology : WJG, 2015-03, Vol.21 (11), p.3197-3205The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. 2015 ;ISSN: 1007-9327 ;EISSN: 2219-2840 ;DOI: 10.3748/wjg.v21.i11.3197 ;PMID: 25805925Full text available |
| 13 |
Material Type: Article
|
|
Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatmentEuropean journal of clinical pharmacology, 2016-10, Vol.72 (10), p.1177-1183 [Peer Reviewed Journal]Springer-Verlag Berlin Heidelberg 2016 ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-016-2091-4 ;PMID: 27395406Full text available |
| 14 |
Material Type: Article
|
|
Efficacy of tolvaptan for chronic heart failure: Study protocol for a systematic review of randomized controlled trialMedicine (Baltimore), 2019-02, Vol.98 (7), p.e14540 [Peer Reviewed Journal]Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000014540 ;PMID: 30762795Full text available |
| 15 |
Material Type: Article
|
|
Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adultsEuropean journal of clinical pharmacology, 2017-11, Vol.73 (11), p.1399-1408 [Peer Reviewed Journal]The Author(s) 2017 ;European Journal of Clinical Pharmacology is a copyright of Springer, 2017. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-017-2302-7 ;PMID: 28803333Full text available |
| 16 |
Material Type: Article
|
|
Vasopressin AntagonistsThe New England journal of medicine, 2015-06, Vol.372 (23), p.2207-2216 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1403672 ;PMID: 26039601Full text available |
| 17 |
Material Type: Article
|
|
Pharmacological interventions for heart failure in people with chronic kidney diseaseCochrane database of systematic reviews, 2020-02, Vol.2020 (2), p.CD012466-CD012466 [Peer Reviewed Journal]Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD012466.pub2 ;PMID: 32103487Full text available |
| 18 |
Material Type: Article
|
|
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseThe New England journal of medicine, 2012-12, Vol.367 (25), p.2407-2418 [Peer Reviewed Journal]Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;2012 Massachusetts Medical Society. All rights reserved. 2012 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1205511 ;PMID: 23121377 ;CODEN: NEJMAGFull text available |
| 19 |
Material Type: Article
|
|
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeNephrology, dialysis, transplantation, 2016-03, Vol.31 (3), p.337-348 [Peer Reviewed Journal]The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. 2016 ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfv456 ;PMID: 26908832Full text available |
| 20 |
Material Type: Article
|
|
Long-term low-dose tolvaptan treatment in hospitalized male patients aged >90 years with hyponatremia: Report on safety and effectivenessMedicine (Baltimore), 2017-12, Vol.96 (52), p.e9539 [Peer Reviewed Journal]Copyright © 2017 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved. ;Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000009539 ;PMID: 29384972Full text available |
Results 1 - 20 of 1,120 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (1,081)
Refine My Results
Creation Date
- Before 1995 (66)
- 1995 To 2001 (266)
- 2002 To 2008 (195)
- 2009 To 2016 (381)
- After 2016 (213)
-
More options
New Records
Resource Type
- Articles (1,118)
- Conference Proceedings (1)
- Book Chapters (1)
-
More options
Subject
- Science & Technology (854)
- Life Sciences & Biomedicine (831)
- Antidiuretic Hormone Receptor Antagonists (798)
- Humans (664)
- Male (610)
- Animals (577)
- Female (376)
- Rats (356)
- Biological And Medical Sciences (293)
- Benzazepines - Therapeutic Use (260)
- Vasopressin (236)
- Tolvaptan (205)
- Middle Aged (204)
- Antidiuretic Hormone Receptor Antagonists - Therapeutic Use (201)
- Medical Sciences (200)
- Receptors, Vasopressin - Metabolism (177)
- Aged (171)
- Arginine Vasopressin - Pharmacology (166)
- Cardiovascular System & Cardiology (162)
- Pharmacology & Pharmacy (154)
-
More options
Databases
- MEDLINE (1,114)
- Geneva Foundation Free Medical Journals at publisher websites (479)
- ProQuest Central (428)
- PubMed Central (268)
- HighWire Press (Free Journals) (219)
- DOAJ Directory of Open Access Journals (161)
- ROAD: Directory of Open Access Scholarly Resources (140)
- Open Access: Wiley-Blackwell Open Access Journals (88)
- ProQuest One Psychology (68)
- Springer_OA刊 (52)
- IngentaConnect (29)
- Open Access: Nature Open Access (24)
- Journals@Ovid Open Access Journal Collection Rolling (22)
- Freely Accessible Japanese Titles (ERDB Project) (15)
- Wolters Kluwer Open Access (9)
- Hyper Article en Ligne (HAL) (Open Access) (9)
- SAGE database (8)
- JSTOR Early Journal Content (Open Access) (8)
- PLoS (8)
- Karger Open Access Journals (7)
-
More options
Language
Journal Title
- American Journal Of Physiology. Regulatory, Integrative And Comparative Physiology (34)
- British Journal Of Pharmacology (21)
- Clinical Journal Of The American Society Of Nephrology (22)
- European Journal Of Pharmacology (31)
- International Heart Journal (21)
- Journal Of Medicinal Chemistry (17)
- Kidney International (22)
- Nephrology, Dialysis, Transplantation (20)
- The American Journal Of Physiology (46)
- The New England Journal Of Medicine (22)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||